PAK2 Antikörper (C-Term)

Produktnummer ABIN500439

Produktdetails anti-PAK2 Antikörper

Target: PAK2 (P21-Activated Kinase 2 (PAK2))

Bindungsspezifität: C-Term

Reaktivität: Human, Maus, Ratte

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser PAK2 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Enzyme Immunoassay (EIA)

Spezifität: This antibody detects PAK2 at C-term.

Kreuzreaktivität (Details): Species reactivity (tested):Human, mouse, rat

Aufreinigung: Peptide affinity chromatography

Immunogen: 14 amino acid peptide from near the carboxy terminus of human PAK2

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: ELISA. Western blot: 0.5 - 1 μg/mL. Immunohistochemistry on paraffin sections.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Konzentration: 1 mg/mL

Buffer: PBS containing 0.02 % sodium azide

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: 4 °C

Informationen zur Lagerung: Store at 2 - 8 °C.

Details zu PAK2

Target: PAK2 (P21-Activated Kinase 2 (PAK2))

Andere Bezeichnung: PAK2 (PAK2 Produkte)

Synonyme: PAK65 antikoerper, PAKgamma antikoerper, gamma-PAK antikoerper, 5330420P17Rik antikoerper, A130002K10Rik antikoerper, AI836325 antikoerper, D16Ertd269e antikoerper, PAK-2 antikoerper, mKIAA4182 antikoerper, pak2 antikoerper, cb422 antikoerper, kinase antikoerper, zgc:91798 antikoerper, wu:fb71h01 antikoerper, si:dz198m22.1 antikoerper, pak65 antikoerper, pakgamma antikoerper, PAKI antikoerper, Pak3 antikoerper, CH73-159L23.1 antikoerper, wu:fc52b03 antikoerper, zgc:113857 antikoerper, p21 (RAC1) activated kinase 2 antikoerper, p21 protein (Cdc42/Rac)-activated kinase 2 antikoerper, p21 protein (Cdc42/Rac)-activated kinase 2a antikoerper, p21 protein (Cdc42/Rac)-activated kinase 2 S homeolog antikoerper, p21 protein (Cdc42/Rac)-activated kinase 2b antikoerper, PAK2 antikoerper, Pak2 antikoerper, pak2a antikoerper, pak2.S antikoerper, pak2b antikoerper

Hintergrund: The p21-activated kinases (PAKs) are serine-threonine kinases that bind to the active forms of Cdc42 and Rac. They are divided into two groups, the first of which include PAK1, 2 and 3, and can be activated by Cdc42/Rac binding. Group 1 PAKs contain an autoinhibitory domain whose activity is regulated by Cdc42/Rac binding. The group 1 PAKs are known to be involved in cellular processes such as gene transcription, apoptosis, and cell morphology and motility. Much less is known about the second group, which includes PAK4, 5 and 6, and are not activated by Cdc42/Rac binding. Of the six PAK proteins, only PAK2 is ubiquitously expressed and cleaved by caspase-3. This cleavage removes the amino-terminal regulatory domain and generates a constitutively active kinase fragment. Recent experiments have shown that following cleavage, the active fragment is myristoylated and directed to the plasma membrane and membrane ruffles where it promotes cell death via increased signaling through the c-Jun N-terminal kinase pathway, but without compromising mitochondrial integrity.Synonyms: Gamma-PAK, PAK 2, PAK gamma, PAK-2, PAK65, Serine/threonine-protein kinase PAK 2, p21-activated kinase 2, p58

Gen-ID: 5062

NCBI Accession: NP_002568

UniProt: Q13177

Pathways: MAPK Signalweg, RTK Signalweg, T-Zell Rezeptor Signalweg, Fc-epsilon Rezeptor Signalübertragung, Regulation of Lipid Metabolism by PPARalpha